# Lifecore Biomedical, Inc. \\de\\: filings

LFCR · Nasdaq · CIK 1005286 · [Healthcare](/sectors/healthcare.md) · fiscal year ends May 25

Pages: [Overview](/companies/lfcr.md) · [Financials](/companies/lfcr/financials.md) · [Filings](/companies/lfcr/filings.md) · [Insiders](/companies/lfcr/insiders.md)

## Reports and events: 359 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 593, 8-K 221, SC 13G/A 65, 10-Q 53, 3 35, 4/A 25, SC 13D/A 25, SC 13G 23, UPLOAD 20, DEF 14A 19, 10-K 17, CORRESP 13, S-8 8, NT 10-Q 6, SCHEDULE 13D/A 6, 144 5, 3/A 5, 8-K/A 5, EFFECT 5, SC 13D 5, SCHEDULE 13G/A 5, PRE 14A 4, SCHEDULE 13G 4, 10-K/A 3, 424B3 3, DEFA14A 3, NT 10-K 3, 10-Q/A 2, S-1 2, S-3 2, 10-KT 1, D 1, POS AM 1, PREM14A 1, S-1/A 1, S-8 POS 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 16:30 ET | [8-K](/filings/0001005286-26-000040.md) | 8.01 Other events | 0001005286-26-000040 |
| 2026-09-29 | 16:15 ET | [SCHEDULE 13D/A](/filings/0001104659-26-111939.md) | Ownership report, active investor, amended | 0001104659-26-111939 |
| 2026-09-29 | 16:12 ET | [8-K](/filings/0001005286-26-000036.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001005286-26-000036 |
| 2026-09-28 | 17:41 ET | [SCHEDULE 13D/A](/filings/0000921895-26-002661.md) | Ownership report, active investor, amended | 0000921895-26-002661 |
| 2026-09-28 | 08:53 ET | [8-K](/filings/0001140361-26-037767.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-037767 |
| 2026-08-05 | 07:20 ET | [10-Q](/filings/0001005286-26-000033.md) | Quarterly report, period 2026-06-30 | 0001005286-26-000033 |
| 2026-08-05 | 07:17 ET | [8-K](/filings/0001005286-26-000032.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-26-000032 |
| 2026-07-02 | 17:36 ET | [SCHEDULE 13D/A](/filings/0000921895-26-001747.md) | Ownership report, active investor, amended | 0000921895-26-001747 |
| 2026-07-02 | 17:17 ET | [8-K](/filings/0001005286-26-000026.md) | 7.01 Regulation FD disclosure | 0001005286-26-000026 |
| 2026-07-02 | 17:15 ET | [SCHEDULE 13D/A](/filings/0001193125-26-294951.md) | Ownership report, active investor, amended | 0001193125-26-294951 |
| 2026-06-05 | 16:10 ET | [8-K](/filings/0001005286-26-000023.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001005286-26-000023 |
| 2026-05-06 | 07:22 ET | [10-Q](/filings/0001005286-26-000020.md) | Quarterly report, period 2026-03-31 | 0001005286-26-000020 |
| 2026-05-06 | 07:17 ET | [8-K](/filings/0001005286-26-000018.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-26-000018 |
| 2026-04-24 | 16:09 ET | [DEF 14A](/filings/0001005286-26-000012.md) | Proxy statement, period 2026-04-24 | 0001005286-26-000012 |
| 2026-03-16 | 08:08 ET | [8-K](/filings/0001005286-26-000007.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-26-000007 |
| 2026-03-05 | 16:33 ET | [8-K](/filings/0001005286-26-000002.md) | 5.08 Item not in the standard list | 0001005286-26-000002 |
| 2026-01-16 | 16:29 ET | [8-K](/filings/0001628280-26-002400.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-002400 |
| 2025-11-17 | 16:10 ET | [8-K](/filings/0001005286-25-000150.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-25-000150 |
| 2025-11-06 | 16:30 ET | [10-Q](/filings/0001005286-25-000148.md) | Quarterly report, period 2025-09-30 | 0001005286-25-000148 |
| 2025-11-06 | 16:26 ET | [8-K](/filings/0001005286-25-000146.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-25-000146 |
| 2025-10-31 | 16:13 ET | [8-K](/filings/0001005286-25-000138.md) | 5.07 Shareholder vote results | 0001005286-25-000138 |
| 2025-09-26 | 16:33 ET | [8-K](/filings/0001005286-25-000133.md) | 5.02 Departure or appointment of officers or directors | 0001005286-25-000133 |
| 2025-09-18 | 16:11 ET | [DEF 14A](/filings/0001005286-25-000126.md) | Proxy statement, period 2025-09-18 | 0001005286-25-000126 |
| 2025-08-18 | 16:31 ET | [8-K](/filings/0001005286-25-000118.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001005286-25-000118 |
| 2025-08-12 | 07:53 ET | [8-K](/filings/0001005286-25-000115.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-25-000115 |
| 2025-08-07 | 16:38 ET | [10-K](/filings/0001005286-25-000108.md) | Annual report, period 2025-05-25 | 0001005286-25-000108 |
| 2025-08-07 | 16:30 ET | [8-K](/filings/0001005286-25-000106.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001005286-25-000106 |
| 2025-07-18 | 16:10 ET | [8-K](/filings/0001005286-25-000097.md) | 5.02 Departure or appointment of officers or directors | 0001005286-25-000097 |
| 2025-05-29 | 21:56 ET | [SCHEDULE 13D/A](/filings/0000950170-25-079298.md) | Ownership report, active investor, amended | 0000950170-25-079298 |
| 2025-04-16 | 16:40 ET | [8-K](/filings/0001005286-25-000072.md) | 5.02 Departure or appointment of officers or directors | 0001005286-25-000072 |
| 2025-04-10 | 16:46 ET | [8-K](/filings/0001005286-25-000061.md) | 5.07 Shareholder vote results | 0001005286-25-000061 |
| 2025-04-03 | 16:23 ET | [10-Q](/filings/0001005286-25-000055.md) | Quarterly report, period 2025-02-23 | 0001005286-25-000055 |
| 2025-04-03 | 16:10 ET | [8-K](/filings/0001005286-25-000052.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-25-000052 |
| 2025-02-27 | 16:05 ET | [DEF 14A](/filings/0001005286-25-000041.md) | Proxy statement, period 2025-02-27 | 0001005286-25-000041 |
| 2025-01-17 | 17:27 ET | [8-K](/filings/0001005286-25-000028.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001005286-25-000028 |
| 2025-01-07 | 09:07 ET | [8-K](/filings/0001005286-25-000014.md) | 7.01 Regulation FD disclosure | 0001005286-25-000014 |
| 2025-01-02 | 17:15 ET | [10-Q](/filings/0001005286-25-000012.md) | Quarterly report, period 2024-11-24 | 0001005286-25-000012 |
| 2025-01-02 | 16:15 ET | [8-K](/filings/0001005286-25-000009.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-25-000009 |
| 2024-12-26 | 13:20 ET | [SCHEDULE 13D/A](/filings/0000950170-24-140227.md) | Ownership report, active investor, amended | 0000950170-24-140227 |
| 2024-11-26 | 17:29 ET | [8-K](/filings/0001005286-24-000169.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-24-000169 |
| 2024-11-21 | 07:55 ET | [8-K](/filings/0001005286-24-000166.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-24-000166 |
| 2024-11-08 | 16:32 ET | [8-K](/filings/0001005286-24-000163.md) | 5.07 Shareholder vote results | 0001005286-24-000163 |
| 2024-10-10 | 16:37 ET | [S-1](/filings/0001628280-24-042662.md) | Registration statement | 0001628280-24-042662 |
| 2024-10-07 | 16:31 ET | [SC 13D/A](/filings/0000921895-24-002253.md) | Ownership report, active investor, amended | 0000921895-24-002253 |
| 2024-10-04 | 07:41 ET | [10-Q](/filings/0001005286-24-000145.md) | Quarterly report, period 2024-08-25 | 0001005286-24-000145 |
| 2024-10-04 | 07:36 ET | [8-K](/filings/0001005286-24-000144.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-24-000144 |
| 2024-09-23 | 16:21 ET | [DEF 14A](/filings/0001005286-24-000139.md) | Proxy statement, period 2024-11-07 | 0001005286-24-000139 |
| 2024-09-23 | 16:14 ET | [8-K](/filings/0001005286-24-000138.md) | 5.02 Departure or appointment of officers or directors; 5.08 Item not in the standard list | 0001005286-24-000138 |
| 2024-09-12 | 07:09 ET | [8-K](/filings/0001005286-24-000130.md) | 8.01 Other events | 0001005286-24-000130 |
| 2024-08-29 | 16:03 ET | [8-K](/filings/0001005286-24-000128.md) | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-24-000128 |

Page 1 of 8. [Older](/companies/lfcr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 17:35 ET. No prices; not investment advice.
